AGEs (advanced glycation-end products) accumulate during aging and several pathologies such as Alzheimer's disease and diabetes. These protein products are known to inhibit proteolytic pathways. Moreover, AGEs are known to be involved in the activation of immune responses. In the present study we demonstrate that AGEs induce the expression of immunoproteasomal subunits. To elucidate a molecular basis underlying the observed effects we were able to demonstrate an activation of the Jak2 (Janus kinase 2)/STAT1 (signal transducer and activator of transcription 1) pathway. Inhibition of Jak2 by AG-490 and STAT1 by specific siRNA (small interfering RNA) abolished AGEinduced expression of immunoproteasomal subunits. Furthermore, silencing of RAGE (receptor for AGEs) revealed that AGEinduced up-regulation of the immunoproteasome is mediated by a RAGE signalling process. Thus we have described for the first time that the signalling pathway of Jak2 and STAT1 activated by AGEs via RAGE is involved in the induction of the immunoproteasome.
INTRODUCTION
Accumulation of AGEs (advanced glycation end-products) in the brain is a feature of aging and neurodegeneration. Additionally, AGEs accumulate in pathological settings such as diabetes, renal failure and inflammatory disorders [1] . AGEs are formed through a series of non-enzymatic reactions between reducing groups of sugars and aldehydes with amino groups in proteins, lipids and nucleic acids [1] . This post-translational modification, also termed glycation or glycosylation, leads via Schiff base adducts and Amadori products through subsequent oxidations and dehydrations to a broad range of heterogeneous products. The final products called AGEs are capable of forming cross-links between proteins leading to protein deposition and amyloidosis [1] . Other pathological features of AGEs include the induction of oxidative stress, production of cytokines and cell death [2] .
Misfolded, damaged or undesired proteins and polypeptides have to be degraded to prevent the accumulation of non-functional and potentially toxic proteins. The proteasome is reported to be one of the major enzymes involved in the degradation of damaged proteins and, additionally, it plays a role in antigen presentation, apoptosis and cellular proliferation [3] . Proteasomes, which exist in several different molecular forms, are large proteolytic complexes in the cytosol and nucleus of almost all cells. The 20S proteasome is the core particle and includes the multienzymatic activity. In eukaryotes it is formed by four stacked heptametrical rings, each comprising α-or β-type subunits arranged in an α 1-7 β 1-7 β 1-7 α 1-7 stoichiometry [3] . Three of the seven different β-subunits are proteolytically active. These are β1 (Y), β2 (Z) and β5 (X), which have specific cleavage preferences known as peptidyl-glutamyl-peptide hydrolysing activity, trypsinlike and chymotrypsin-like activities respectively [3] . The α-subunits are highly conserved and involved in the formation of the proteasome structure as they interact with a variety of regulatory complexes such as PA700/19S or PA28/11S [3] . The different regulators execute various tasks such as recognition, unfolding and translocation of the substrates, as well as supporting the correct assembly of the different subunits to the entire proteasome. The PA700/19S regulator is involved in the ubiquitinmediated pathway, which is responsible for the degradation of most intracellular proteins. PA700/19S forms a complex with the 20S core particle to generate the 26S proteasome [3] . Ubiquitin is tagged to redundant proteins forming chains of several ubiquitin molecules. These chains are recognized by the 19S regulator. In addition, proteasomes can degrade proteins by ubiquitinindependent mechanisms [3] .
IFN-γ (interferon-γ ) is able to activate macrophages and induce alterations in the subunit composition of the proteasome [4] . In this respect, the constitutive catalytic β subunits (β1, β2 and β5) are replaced by IFN-γ -inducible catalytic subunits LMP2 (β1i), MECL1 (β2i) and LMP7 (β5i). They assemble together with the IFN-γ -inducible PA28/11S regulator to form the immunoproteasome, with a distinct subunit composition and altered catalytic specificity. This leads to the assumption that the immunoproteasome plays an important role in immune recognition of infected host cells. Immunoproteasomes are long thought to be responsible for the liberation of peptides that are presented by MHC class I molecules on the cell surface [5] ; however, current reports claim that the overall effect of immunoproteasomes is to simply alter the repertoire of foreign peptides generated [6] . In agreement with this, a recent study suggested that the immunoproteasome may remove oxidized proteins that accumulate after IFN-induced oxidative stress [4] . A previous study has also reported that the ratio of the immunoproteasome is increased in the aged brain [7] . It is further reported that immunoproteasome expression is Abbreviations used: AGE, advanced glycation-end product; DTT, dithiothreitol; FBS, fetal bovine serum; Fru, D-fructose; G, glyoxal; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Glc, D-glucose; IFN, interferon; Jak, Janus kinase; MAPK, mitogen-activated protein kinase; MG, methylglyoxal; NF-κB, nuclear factor κB; RAGE, receptor for AGEs; Rib, D-ribose; siRNA, small interfering RNA; STAT, signal transducer and activator of transcription. 1 To whom correspondence should be addressed (email tilman.grune@uni-jena.de).
increased in brain regions where senile plaques are present [8] .
As senile plaques often contain AGEs, we raised the question whether AGEs are able to induce the expression of immunoproteasomal subunits. In the present study our aim was to study the effect of an activated Jak (Janus Kinase)/STAT (signal transducer and activator of transcription) pathway on the expression of immunoproteasomal subunits, as it has been shown that this pathway is involved in up-regulation of immunoproteasome expression in IFN-γ -stimulated cells [9] . Additionally, our purpose was to investigate which upstream receptor is required for the induction of the immunoproteasome.
AGEs are known to increase oxidative stress and inflammation through binding to RAGE (receptor for AGEs) [10] . RAGE belongs to the immunoglobulin superfamily, consisting of three immunoglobulin-like domains (one variable type and two constant type) in the N-terminal extracellular part, one transmembrane domain and a short C-terminal cytoplasmic trail that is essential for RAGE-mediated signal transduction [11] . The V-domain (variable domain) of RAGE is critical for the binding of various ligands, like AGEs [11] and others such as HMGB1 (highmobility group box-1)/amphoterin [12] , S100 [13] , Mac-1 [14] and amyloid β [15] . It is well investigated that RAGE activation leads to a signalling pathway which induces NF-κB (nuclear factor κB) liberation from IκB (inhibitor of NF-κB) and NF-κB translocation to the nucleus leading to the transcription of pro-inflammatory factors.
In the present study we provide data to support the conclusion that AGEs trigger an increase in mRNA and protein expression of immunoproteasomal subunits. We also report for the first time that AGEs are able to induce the immunoproteasome expression via the activation of RAGE and downstream activation of Jak2/STAT1.
EXPERIMENTAL

Materials
RPMI 1640 medium, penicillin (10 000 units)/streptomycin (10 000 μg/ml), FBS (fetal bovine serum) and PBS (pH 7.4) were purchased from Biochrom. Mouse Ifn-γ (10 6 units/ml) was from Miltenyi Biotec. The Jak2 inhibitor AG-490 was obtained from Enzo Life Sciences. Other chemicals were of the best grade available from Sigma-Aldrich or from Carl Roth. The murine macrophage cell line RAW264.7 was used for cell culture experiments.
Preparation of AGE-modified BSA
AGEs were produced as described previously [16] . Briefly, 1 mM fatty-acid-free, endotoxin-free BSA was dissolved in PBS with 250 mM Glc (D-glucose), Fru (D-fructose), Rib (D-ribose) and 20 mM G (glyoxal) and MG (methylglyoxal). Additionally, 1 mM of fatty-acid-and endotoxin-free BSA was prepared without sugars and aldehydes. These preparations were sterilized by ultrafiltration and incubated at 37
• C for 6 weeks (sugars and pure BSA) and 1 week (aldehydes). Oxygen was present, but not added throughout the incubation phase. Metal ions were just present in a very small amount (under 10 p.p.m.) in sugars, aldehydes, albumin and PBS according to the certifications of the manufacturer. To remove unbound sugars or aldehydes the preparations were dialysed against PBS over 24 h followed by measurement of protein content with the Bradford assay in order to verify the BSA concentration of 1 mM. To confirm AGE formation, the preparations were determined for their optical density and fluorescence [16] . In the present study we used the same AGEs that were characterized for their absorbance, fluorescence intensity, protein cross-linking and protein oxidation as described previously [16] .
Cell culture
The RAW264.7 cell line was grown in RPMI 1640 culture medium supplemented with 10 % FBS and 1 % penicillin/streptomycin. Cells were kept at 37
• C in 5 % CO 2 and 95 % humidity. The cells were passaged twice weekly when reaching 80 % confluence. For the cell culture experiments cells were plated at a density of 2×10 5 in RPMI 1640 culture medium with reduced FBS (2 %) for 3 days. After 3 days AGEs were delivered to the cells in reduced FBS medium for a different time period. The final concentrations of AGEs used in these studies were albumin-modified with 25 mM of the indicated sugar or 2 mM of the aldehyde. In the case of dose-dependent investigations, cells were incubated with sugar-(25 mM, 12.5 mM or 6 mM) modified albumin or aldehyde-(2 mM, 1 mM or 500 μM) modified albumin. The final concentration of modified albumin was 100 μM in all experiments. In order to apply the same protein concentration to each sample, we used 100 μM fresh BSA for the control samples and BSA that was incubated under the same conditions as AGEmodified albumin for the BSA samples. We characterized fresh and incubated BSA according to a method described previously [16] . In some experiments IFN-γ was added to the cells in a final concentration of 250 units/ml for 72 h as a positive control. The activity of Jak2 was inhibited by AG-490. Accordingly AG-490 was dissolved in DMSO and further diluted in medium to a final DMSO concentration of <0.1 %. Cells were treated with 10 μM or 30 μM AG-490 1 h before they were stimulated with AGE-modified albumin or IFN-γ .
Preparation of cell lysates and measurement of proteasomal and immunoproteasomal activity
For the determination of proteasomal activity and the preparation of cell lysates for immunoblotting, 2×10 6 cells were harvested, centrifuged for 5 min at 900 g at 4
• C and the cell pellet was resuspended in lysis buffer [250 mM sucrose, 25 mM Hepes, 10 mM magnesium chloride, 1 mM EDTA and 1.7 mM DTT (dithiothreitol)]. Cells were lysed using a syringe, followed by repeated freeze-thaw cycles. Cell lysates were used for the determination of protein content using the Bradford assay, the measurement of proteasomal activity and the expression of proteins.
For proteasomal activity cell lysates were incubated in 225 mM Tris buffer (pH 7.8), 45 mM potassium chloride, 7.5 mM magnesium acetate, 7.5 mM magnesium chloride and 1 mM DTT.
The substrates for the constitutively expressed proteasome and the immunoproteasome were chosen according to Blackburn et al. [17] . The substrates were obtained from AAT Bioquest to monitor the activity of the constitutive proteasome (c) and immunoproteasome (i): β1c, Z-LLE-R110; β2c/β2i, Ac-KQL-R110; β5c, Ac-WLA-R110; β1i, Ac-PAL-R110; and β5i, Ac-ANW-R110 (where R110 is rhodamine 110). R110 liberation was measured using a fluorescence reader at 485 nm excitation and 528 nm emission for 30 min at 37
• C. Free R110 was used as a standard for quantification.
Immunoblot analysis
To detect the influence on protein expression 2×10 6 control or treated cells were harvested, lysed and the protein In order to determine the β1i and β5i activity of the immunoproteasome, cells were lysed after 72 h of incubation with AGEs. Controls (C) were set to 100 % and the treated cells were counted referred to the control sample. The statistical significance between control and AGE-treated cells is indicated by *P < 0.05, **P < 0.01 and ***P < 0.001 and the statistical significance between cells treated with incubated BSA and AGEs is shown as # P < 0.05, ## P < 0.01 and ### P < 0.001 (means + − S.D. for four independent experiments). concentration was measured as described above. Protein extract (20-50 μg) was subjected, in Laemmli buffer, to SDS/PAGE (12 % gel) and the separated proteins were transferred on to nitrocellulose transfer membranes (Whatmann). Blots were blocked in 5 % non-fat milk/PBS buffer at room temperature (22
• C) for 1 h. Before detection of phosphorylated proteins, the blots were blocked in Odyssey ® blocking buffer (LI-COR Biosciences) at 4
• C overnight. Blocking was followed by incubation with primary antibodies that were diluted according to the recommendations of the manufacturers under constant agitation for another hour. The following primary antibodies were used: and anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Abcam). After being washed three times, the blots were incubated with the appropriate secondary antibody: goat anti-(rabbit IRDye ® 800CW conjugated) or donkey anti-(mouse IRDye ® 680LT conjugated) (LI-COR Biosciences) for 1 h. Blots were washed and analysed for their near-infrared fluorescence signals with the Odyssey ® infrared imaging system (LI-COR Biosciences).
Quantitative PCR
Total RNAs were extracted from cells using the RNeasy Mini kit as described by the manufacturer (Qiagen) and RNA integrity was checked with the Agilent RNA 6000 nano kit (Agilent Technologies). Total RNA (2 μg) was transcribed into cDNA using oligo(dT [12] [13] [14] [15] [16] [17] [18] ) primer, Superscript TM II reverse transcriptase and 10 mM dNTP mix from Invitrogen according to the manufacturer's recommendations. A standard real-time PCR with a total volume of 25 μl was performed with 1 μl of the reverse transcriptase reaction mixture in 35 cycles, each with 95
• C for 30 s, followed by 55
• C for 30 s and 72
• C for 30 s. The reaction mixture contained 10 mM dNTPs, 5 units/μl GoTaq DNA polymerase and Green buffer (Promega) and 10 pmol of the specific primers. The thermal cycler for quantitative real-time PCR was the iCycler IQ Multicolor Real Time PCR Detection system (Bio-Rad Laboratories). The primers were synthesized by biomers.net were: GAPDH, 5 -AACCTGCCAAGTATGATGACA-3 and 5 -CATA-CCAGGAAATGAGCTTGA-3 ; 18S rRNA, 5 -ATTAAGTCCC-TGCCCTTTGTA-3 and 5 -AGTCAAGTTCGACCGTCTTCT-3 ; β-actin, 5 -TTCCTTCTTGGGTATGGAATC-3 and 5 -GCTAGGAGCCAGAGCAGTAAT-3 ; RAGE, 5 -CACAGCCA-GTGTCCCTAATAA-3 and 5 -CTCTGACCGCAGTGTAAA-GAG-3 ; β1i (LMP2), 5 -GCTAATTCGACAGCCCTTTAC-3 and 5 -ACTAGAGCCATCTCGGTTCAT-3 ; and 11Sα (PA28), 5 -AAGCAACAGGAGAAGGAAGAG-3 and 5 -GTAGC-TGCAACCAGGTAGTGA-3 .
The GAPDH PCR product was 192 bp, 18S rRNA was 134 bp and β-actin was 178 bp long. The RAGE PCR product was 175 bp, β1i (LMP2) was 154 bp and 11Sα (PA28) was 178 bp long. Quantification of gene expression was based on the cycle threshold (C T ) value for each sample considering PCR efficiency using the relative expression software tool REST 2008 (Corbett Life Science). Three different housekeeping genes were used. All experiments included negative controls consisting of no cDNA for each primer pair base.
RNA interference
Cells were transfected with Accell SMARTpool AGER (11596), Accell SMARTpool STAT1 (20846) or Accell non-targeting pool (Thermo Fisher Scientific) utilizing the Accell siRNA (small interfering RNA) delivery protocol. RAW264.7 cells were plated at a density of 2×10 5 cells in RPMI 1640 medium with 10 % FBS. The next day medium was replaced with 3 ml of Accell delivery medium containing 1 μM siRNA and cells were incubated for 24, 48 or 72 h at 37
• C. After 72 h, cells were stimulated with AGEs or IFN-γ for another 72 h at 37
• C.
Statistical analysis
All experiments were performed at least in triplicate. The statistical analysis of the data was performed using one-way ANOVAs followed by post-hoc Tukey's significant difference test.
Results are means + − S.D. and statistical analysis was performed using GraphPad Prism version 5.
RESULTS
Proteasomal activity and the expression of proteasomal subunits
In order to determine the effect of AGEs on the proteasomal activity in RAW264.7 cells, we used specific proteasomal substrates.
Figure 3 Proteasomal β-subunit expression after AGE treatment
Relative protein expression of β1 (A), β2 (B), β5 (C), β1i (D), β2i (E) and β5i (F) was determined in cell lysates after 72 h of incubation with fresh protein (as a control), incubated BSA (BSA), G-, MG-, Glc-, Rib-or Fru-modified albumin. One representative blot is displayed below each diagram. The inset in (D) shows the positive control IFN-γ for its induction of β1i compared with the control cells. Controls were set to 100 % and the other cells were counted referred to the control sample. The statistical significance between control and AGE-treated cells is shown as *P < 0.05, **P < 0.01 and ***P < 0.001 and the statistical significance between cells treated with incubated BSA and AGEs is shown as # P < 0.05, ## P < 0.01 and ### P < 0.001 (means + − S.D. for three independent experiments).
The samples used in the following studies include control samples (with freshly dissolved BSA), BSA samples (with BSA incubated for 6 weeks), G-, MG-, Glc-, Rib-and Fru-modified albumin. As the incubated BSA showed some characteristics of modification and oxidation due to traces of oxygen, aldehydes, metals and sugars when subjected to SDS/PAGE and autofluorescence analysis, we calculated our results in comparison with fresh BSA (control samples) and, therefore, to our BSA samples (incubated BSA). We included the incubated BSA probe (BSA) in our experiments to demonstrate that the observed effects were exerted largely due to AGEs. A significant decrease in the constitutive proteasomal activity was measured for all AGEs and catalytic subunits after 72 h compared with the control and BSA samples ( Figure 1A ). To investigate whether the decreased activity is due to a reduction in proteasomal subunit expression, we quantified the relative expression of the total 20S proteasome using a polyclonal antibody ( Figure 1B ) and the expression of α-subunits ( Figure 1C) . Interestingly, both analyses showed a significant increase in protein expression. It can be assumed that decreased proteasomal activity is compensated by increased immunoproteasomal activity [18] and therefore we studied immunoproteasomal activity after incubation with AGE-modified proteins ( Figure 1D ). To date, two specific substrates are available for β1 and β5 of the immunoproteasome (β1i and β5i) . Both of these substrates demonstrated an increase in its catalytic activity.
In order to reveal if the influence on proteasomal activity is obvious at the protein level, we studied the expression of the catalytic subunits by immunoblotting.
Determination of proteasomal activity was carried out after 72 h to observe any chronic effect. The influence of AGEmodified proteins on the expression of proteasomal subunits could probably start earlier. Thus we determined the time-dependent expression of β1 and β1i (Figures 2A and 2B) . G-modified albumin reduces the expression of β1 and enhances the expression of β1i over a period of several hours. After 72 h we could detect sufficient decreased β1 and increased β1i expression (Figures 2A and 2B) . To further analyse the conditions for reduced constitutive and increased inducible proteasomal subunit expression, we studied a dose-dependent effect of G-and Glcmodified albumin on β1 and β1i ( Figures 2C and 2D) . A slight dose-dependent reduction of β1 expression was observed with G-and Glc-modified albumin ( Figure 2C ). On the other hand, Gand Glc-modified albumin induced the expression of β1i in a dose-dependent manner ( Figure 2D ). The most obvious effects were observed with the highest G-and Glc-modified albumin concentrations. Therefore we used 25 mM of sugar-modified and 2 mM of aldehyde-modified albumin for further experiments. As shown in Figure 3 we characterized the influence of several sugar-and aldehyde-modified albumins on different proteasomal catalytic subunits after a chronic exposure (72 h). AGE-modified proteins significantly reduced all three constitutive proteasomal subunits (β1, β2 and β5) (Figures 3A-3C ). On the other hand, immunoblotting of the same cell lysates displayed a 20-40 % increase in the catalytic immunoproteasomal subunits β1i, β2i and β5i ( Figures 3D-3F) . Additionally, the cell lysates demonstrated an increase (50-100 %) in the regulator of the immunoproteasome 11Sα compared with the untreated cells ( Figure 4 ). These results indicate that the immunoproteasome is induced within 72 h of macrophage-stimulation by AGEs.
Effect of AGEs on the phosphorylation of STAT1 and Jak2
Next we decided to investigate the pathway of immunoproteasome induction. Activation of Jak/STAT has been associated with inflammatory-related stimulation and immunoproteasome induction [9] . The transcriptional activity of STAT1 requires phosphorylation at Tyr 701 by Jak2 [19] . Thus we examined whether AGEs activate the Jak/STAT pathway in RAW264.7 cells. The involvement of Jak2 and STAT1 in IFN-γ signalling has been well characterized and therefore we used INF-γ as a positive control (demonstrated by the inset in both panels of Figure 5 ). Immunoblot analysis showed significantly enhanced phosphorylated STAT1(Tyr 701 ) and Jak2(Tyr 1007/1008 ) after 72 h of AGE-stimulation compared with unstimulated cells (Figure 5 ). Equal amounts of STAT1 and Jak2 were measured in all conditions, indicating that differences detected with the phosphotyrosine-specific antibodies (pSTAT1 and pJak2) were not due to differences in the amount of total STAT1 and Jak2 loaded into each lane.
Expression and role of RAGE in AGE-treated macrophages
Consequently, this led to the following question: which proteins or receptors upstream of Jak/STAT are involved? One possible receptor is RAGE which is believed to play a role in several signalling pathways [10] . Therefore we tested the presence and the amount of RAGE after AGE stimulation. RAW264.7 cells have been incubated with AGEs for 72 h followed by the preparation of cell extracts and quantitative real-time PCR as well as immunoblot analysis. The PCR analysis revealed that RAGE mRNA was significantly increased after 72 h of AGE incubation ( Figure 6A ). Similar results were found in immunoblotting assays showing a significantly higher RAGE protein expression ( Figure 6B ) owing to AGE stimulation. This raises the question of a mechanistic involvement of RAGE in immunoproteasome induction. Therefore we decided to use siRNA for the reduction of the amount of RAGE in RAW cells. A time-dependent decline in RAGE expression was measured after 24, 48 and 72 h of incubation with siRNA ( Figure 6C ). After a 72 h incubation with siRNA only 5 % of RAGE expression was left when compared with the untreated controls ( Figure 6C ). Therefore the use of RAGE siRNAs resulted in markedly reduced RAGE expression. To control for possible off-target effects of siRNA, a separate sample was used with a scrambled siRNA [NTC (nontarget siRNA)] as a negative control. No influence on RAGE expression was detected after a 72 h incubation with the NTC siRNA.
RAGE silencing was able to prevent Jak2 and STAT1 phosphorylation after G-modified albumin treatment, as shown in Figures 7(A) and 7(B) . Most interestingly, no difference in Jak2 and STAT1 activation of IFN-γ was detected after treatment with RAGE siRNA. Additionally, no influence on Jak2 and STAT1 was determined in the treatment with the NTC and RAGE siRNAs. The differences detected with the phosphotyrosine-specific antibodies (pSTAT1 and pJak2) were not due to differences in the amount of total STAT1 and Jak2 in each lane as equal amounts of STAT1 and Jak2 were detected for all samples (Figures 7A and 7B ).
In agreement with these results, the expression of β1i and 11Sα after stimulation with G-modified albumin was significantly reduced in the RAGE siRNA-treated samples ( Figures 7C and  7D) . In contrast, IFN-γ -treated cells with or without siRNA treatment displayed no differences in the protein expression of β1i and 11Sα. In both samples the protein expression of the immunoproteasomal subunits was significantly increased. Again, the NTC and RAGE siRNAs had no impact upon the protein expression of β1i and 11Sα. This let us to the conclusion that the AGE-mediated pathway of immunoproteasome induction and the IFN-γ -mediated pathway are different, at least upstream of Jak/STAT. Controls were set to 100 % and the other cells were counted referred to the control sample. The statistical significance between the control and AGE-treated cells is indicated as **P < 0.01 and ***P < 0.001 and the statistical significance between cells treated with incubated BSA and AGEs is shown by ## P < 0.01 and ### P < 0.001. Time-dependent silencing of RAGE was determined by immunoblot (C). Relative protein expression after siRNA-treatment was calculated to each control (C; 100 %) and a non-target control siRNA (NTC) was used over a time period of 72 h and calculated to the 72 h control sample (means + − S.D. for three independent experiments).
Effect of Jak2 and STAT1 inhibition on the induction of immunoproteasome
It was previously established that AG-490 acts as a Jak-specific inhibitor [20] . Thus we used 10 μM and 30 μM AG-490, as no effect on cell viability was observed (results not shown). Treatment with AG-490 significantly reduces STAT1 activation after G-modified albumin and IFN-γ treatment ( Figure 8 ). As STAT1 is a transcription factor for the immunoproteasomal subunits [9] , further experiments should reveal if the induction of the immunoproteasome is influenced by AG-490 inhibition Relative protein phosphorylation or protein expression after siRNA treatment and stimulation with G-modified albumin (G) and IFN-γ was measured for pJak2 (A), pSTAT1 (B), β1i (C) and 11Sα (D). Non-target siRNA control (NTC) was also tested in each experiment. Cells have been incubated with siRNA or NTC for 48 h, followed by the addition of G-AGE (G) or IFN-γ for a further 72 h. Controls were set to 100 % and the other probes were counted referred to the control sample. The statistical significance between control and AGE-or IFN-γ -treated cells is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001 and the statistical significance between stimulated cells with and without siRNA is indicated as +++ P < 0.001 (means + − S.D. for three independent experiments).
of Jak2. Indeed, β1i mRNA was significantly reduced in Gmodified albumin and IFN-γ -treated cells in the presence of AG-490 ( Figure 9A ). The same effect was observed in the β1i protein expression rate ( Figure 9C ). To confirm that AG-490 reduces the expression of immunoproteasomal subunits, we decided to investigate the regulator 11Sα in addition to β1i. As shown in Figure 4 , we demonstrated that IFN-γ and AGEs are able to stimulate the expression of 11Sα. Figure 9 (B) shows that IFN-γ and G-or Glc-modified albumin induced 11Sα mRNA, whereas both concentrations of AG-490 abolished the increased mRNA expression. Immunoblot analysis verified the enhanced 11Sα expression owing to IFN-γ and AGEs. Also, in this case,
we measured an inhibition effect of AG-490 on the induction of 11Sα ( Figure 9D ). Another way to inhibit the Jak2/STAT1 signalling pathway is to silence the expression of STAT1 by a specific siRNA. Cell viability was tested and we could not measure any influence of 1 μM siRNA after a 72 h incubation. The expression of STAT1 was reduced up to 70-75 % in siRNA-treated samples ( Figure 10A ). Thus the activity of STAT1 (pSTAT1) was significantly reduced in siRNA-treated G-modified albumin-and IFN-γ -stimulated cells ( Figure 10B ). As suspected from previous studies, the induction of β1i and 11Sα was significantly inhibited in STAT1-silenced cells (Figures 10C and 10D) . RAW264.7 macrophages were incubated with AG-490 (10 μM or 30 μM) for 48 h followed by the stimulation with G-or Glc-modified albumin or IFN-γ . Untreated cells were set to 100 % and the other samples were calculated according to the 100 % control. The statistical significance between control and AGE-or IFN-γ -treated cells is indicated as **P < 0.01 and ***P < 0.001 and the statistical significance between stimulated cells with and without AG-490 is demonstrated as ++ P < 0.01 and +++ P < 0.001 (means + − S.D. for three independent experiments).
DISCUSSION
In order to determine the effect of AGEs on the inflammation status of macrophages, we performed experiments using the macrophage cell line RAW264.7 and sugar-or aldehyde-modified albumin. First, experiments were performed with different concentrations of AGEs and different incubation times (4-96 h) (results not shown). Cell viability is reduced by higher AGE concentrations and longer incubation times. As AGEs are known to be formed over a longer period of time the effect of chronic activation would be more interesting. Thus we incubated the cells for 72 h where no effect on cellular viability or proliferation was observed (results not shown), but at the same time significant cellular consequences are obvious (Figure 2 ). RAW264.7 macrophage activation by AGEs leads to a reduced constitutive proteasomal activity and slightly reduced constitutive proteasomal subunits, but increased immunoproteasomal components (Figure 1-4) . Moheimani et al. [21] investigated the short-term effect of AGE-modified proteins on the proteasomal function in cell extracts of J774A.1 macrophages. Similar to the present study they showed that proteasomal activity is decreased due to glycated proteins in this mouse macrophage model. However, Moheimani et al. [21] measured proteasomal activity after a 5 min incubation with different glycated BSA concentrations in cell extracts. The present study shows that the activity of the constitutive proteasome is also decreased after chronic (72 h) incubation of whole cells. We used whole cells in order to compare the results from activity investigations with the effects on expression levels. Thus we were able to show that reduced constitutive proteasomal activity is probably due to a reduced expression of these catalytic subunits. A possible explanation for reduced proteasomal activity is reported by Rivett et al. [22] . They theorized that reduced proteolytic activity is due to reduced proteolytic capacity of the immunoproteasome for the degradation of ubiquitin-tagged and oxidized aggregated proteins [22] . Impaired proteasomal activity has also been reported in various biological phenomena including aging. Chondrogianni et al. [23] have shown that a down-regulation of β-subunits is responsible for the decreased proteasomal activity in senescent human fibroblasts. Beyond this, there are unequivocal evidences that proteasomal activity is decreased in the Alzheimer's disease brain. For example, Gregori et al. [24] indicated that β-amyloid inhibits proteasomal activity. Therefore normal and damaged proteins are less degraded as a consequence of reduced proteasomal activity. Moreover, inhibitors of proteasomal activity have been found to impede the degradation of signalling molecules such as STAT1, Jaks and cytokine receptors [25, 26] . These studies have determined that signalling activity is prolonged owing to less proteasomal activity. It has been reported by several laboratories that LMP2 overexpression (β1i) reduces the caspase-like activity (β1) of the proteasome. Additionally, incorporation of LMP2 (β1i) led to a slight increase in the chymotrypsin-like activity [27] . Thus the replacement of β1 with LMP2 leads to a shift in proteolytic activities. It is generally assumed that the induction of the immunoproteasome serves to generate a different spectrum of peptide products and to alter the kinetic behaviour of the proteasomal system. Transfection of the immunoproteasome regulator PA28α (11Sα) alone has been reported to enhance class I presentation of some antigens [28] . IFN-γ increases the level of immunoproteasomes [29] . Thus we used IFN-γ as a positive control in the present study. Our results show for the first time that the immunoproteasome is induced The influence of AG-490 on the mRNA (A) and protein expression (C) of β1i and on the mRNA (B) and protein expression (D) of 11Sα is shown. Cells have been incubated with AG-490 for 1 h. Subsequently, cells have been stimulated with G-or Glc-modified albumin or IFN-γ . Untreated cells were set to 100 % and the other probes were calculated according to the untreated sample. The statistical significance between control and AGE-or IFN-γ -treated cells is indicated as **P < 0.01 and ***P < 0.001 and the statistical significance between stimulated cells with and without AG-490 is indicated as ++ P < 0.01 and +++ P < 0.001 (means + − S.D. for three independent experiments).
due to AGEs via the RAGE signalling pathway. RAGE siRNA treatment revealed that AGEs induce the activation of Jak2 and STAT1 via RAGE, whereas we could not measure any inhibitory effect on IFN-γ -induced Jak2 and STAT1 activation. Subunits of the immunoproteasome have also been reported to be induced by heat stress [30] , nitric oxide [31] or in neurodegenerative diseases [32] . Consequently the expression of the immunoproteasome may be initiated due to diverse pathological situations, supporting more functions of the immunoproteasome apart from antigen processing. RAGEs are predominantly studied for their role in inflammation, atherosclerosis, diabetes, cancer and neurodegenerative diseases [33] [34] [35] [36] [37] . Moreover, the accumulation of RAGE ligands has been shown to amplify inflammation in diabetic animal models [38] . It is generally accepted that AGEs contribute to an extensive inflammation status due to RAGE stimulation [39] . Binding of AGEs to RAGE initiates cellular signals that activate NF-κB, which results in the transcription of diverse pro-inflammatory cytokines. The RAGE promoter contains NF-κB-binding sites that are involved in the regulation of RAGE expression [40] . Therefore activation of NF-κB results in increased RAGE expression and prolonging NF-κB activation.
We demonstrated that AGEs enhance the expression of RAGE ( Figures 6A and 6B ) and thus sustained RAGE expression leads to chronic activation of inflammation. Binding of ligands to RAGE activates ERK1/2 (extracellular-signal-regulated kinase 1/2; p44/p42) MAPKs (mitogen-activated protein kinases), p38 and SAPK (stress-activated protein kinase)/JNK (c-Jun N-terminal kinase) MAPKs in monocytes, macrophages and tumour cells [41] [42] [43] [44] . Furthermore, Rho-GTPases and phosphoinositide 3-kinase are implicated in RAGE signalling [45] . To date, the only pathway in which RAGE induces the activation of Jak/STAT is described by Huang et al. [46] and Shaw et al. [47] . Huang et al. [46] showed that AGEs induce collagen production in fibroblasts via binding to RAGE and activation of Jak/STAT. Shaw et al. [47] observed that incubation of vascular smooth muscle cells with the RAGE ligand S100B induces tyrosine phosphorylation of Jak2 which was still maintained after 24 h. This study reveals that the activation of Jak2 via RAGE induces a longer lasting signalling response. The Jak/STAT pathway is known to be primarily involved in the regulation of growth and development as well as in inflammation. Different external ligands bind receptors and induce the activation of the Jak/STAT pathway. The ligands The influence of a specific STAT1 siRNA on the expression of STAT1 (A) and thus of phospho-STAT1 (pSTAT1) (B) is shown. Cells have been incubated with siRNA or non-target siRNA (NTC) for 48 h, followed by the addition of G-AGEs or IFN-γ for further 72 h. The expression of β1i (C) and 11Sα (D) is determined after incubation with siRNA or NTC and G-AGEs or IFN-γ -stimulation. Untreated cells were set to 100 % and the other probes were calculated according to the untreated sample. The statistical significance between control and siRNA-, AGE-or IFN-γ -treated cells is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001 and the statistical significance between stimulated cells with and without siRNA is indicated as ++ P < 0.01 and +++ P < 0.001 (means + − S.D. for three independent experiments).
are mainly cytokines, such as IFN, but the pathway may also be activated by different receptor tyrosine kinases, e.g. EGFR (epidermal growth factor receptor), PDGFR (platelet-derived growth factor receptor), non-receptor tyrosine kinases and GPCRs (G-protein-coupled receptors). Cell-surface receptors act by phosphorylation of STATs following by their dissociation from the membrane and dimerization before entering the nucleus. STAT1 is reported to bind to GASs (gamma activating sequences) in order to up-regulate expression of diverse inflammatory proteins such as LMP2 [9] . The signalling cascades leading to the induction of immunoproteasomes and involving the IFN-γ receptor or RAGE are depicted in Figure 11 .
The function of the immunoproteasome in AGE-exposed cells is still unknown. However, the identification of a new class of proteasome inhibitors that preferentially inhibit the constitutive or the inducible catalytic active sites may help to reveal their functional roles in the future.
In summary, malfunction of the proteasome-ubiquitin system might lead to potentially pathogenic protein aggregation, a hallmark for a variety of neurodegenerative and other inflammatory disorders. These protein aggregates such as aggregated AGE-modified proteins trigger chronic inflammatory responses that might affect expression of many molecules such as cytokines and, as shown in the present study, immunoproteasomal subunits. Such a response can ultimately Binding of IFN-γ results in IFN-γ receptor (IFNGR 1 + 2) oligomerization followed by phosphorylation of Jak1 or Jak2. Phosphorylated, and therefore activated, Jaks phosphorylate receptor tyrosine residues, which then serve as docking sites for STAT1. Once recruited to the receptor STAT1 becomes phosphorylated by Jaks. Phosphorylated STAT1 homodimerizes and binds together with IFN regulatory factor-1 (IRF-1) to members of the GAS (gamma activated sequence) family of enhancers and IRF-1 to IFN-stimulated response element (ISRE). Binding of AGEs on RAGE activates Jak2 which induces the phosphorylation of STAT1.
influence the development and clinical severity of multiple neurodegenerative diseases. As AGEs are known to induce chronic inflammation it is of great relevance to find substances that are able to ameliorate tissue-associated diseases that are triggered by AGEs.
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